Phospholipid complex based nanoemulsion system for oral insulin delivery: preparation, in vitro, and in vivo evaluations

References

• Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann Intern Med. 2006;144(7):465–474.16585660
   PubMed Web of Science ®Google Scholar
• Owens DR, Zinman B, Bolli G. Alternative routes of insulin delivery. Diabetic Medicine. 2003;20(11):886–898.14632713
   PubMed Web of Science ®Google Scholar
• Li P, Nielsen HM, Mullertz A. Oral delivery of peptides and proteins using lipid-based drug delivery systems. Expert Opin Drug Deliv. 2012;9(10):1289–1304. doi:10.1517/17425247.2012.71706822897647
   PubMed Web of Science ®Google Scholar
• Rai VK, Mishra N, Agrawal AK, Jain S, Yadav NP. Novel drug delivery system: an immense hope for diabetics. Drug Deliv. 2016;23(7):2371–2390. doi:10.3109/10717544.2014.99100125544604
   PubMed Web of Science ®Google Scholar
• Cui M, Wu W, Hovgaard L, Lu Y, Chen D, Qi J. Liposomes containing cholesterol analogues of botanical origin as drug delivery systems to enhance the oral absorption of insulin. Int J Pharm. 2015;489(1–2):277–284. doi:10.1016/j.ijpharm.2015.05.00625957702
   PubMedGoogle Scholar
• Sharma G, Wilson K, van der Walle CF, Sattar N, Petrie JR, Ravi Kumar MN. Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm. 2010;76(2):159–169. doi:10.1016/j.ejpb.2010.07.00220655382
   PubMed Web of Science ®Google Scholar
• Shi K, Fang Y, Kan Q, Zhao J, Gan Y, Liu Z. Surface functional modification of self-assembled insulin nanospheres for improving intestinal absorption. Int J Biol Macromol. 2015;74:49–60. doi:10.1016/j.ijbiomac.2014.11.01325433129
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Neufeld RJ, Veiga F, Carvalho RA, Figueiredo IV. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles. Eur J Pharm Sci. 2010;41(3–4):556–563. doi:10.1016/j.ejps.2010.08.00920800679
   PubMed Web of Science ®Google Scholar
• Li Y-J, Hu X-B, Lu X-L, et al. Nanoemulsion-based delivery system for enhanced oral bioavailability and Caco-2 cell monolayers permeability of berberine hydrochloride. Drug Deliv. 2017;24:1.
   Web of Science ®Google Scholar
• Wu J-Y, Li Y-J, Han M, et al. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations. Drug Dev Ind Pharm. 2018;44(8):1336–1341.
   Web of Science ®Google Scholar
• Ge L, He X, Zhang Y, et al. A dabigatran etexilate phospholipid complex nanoemulsion system for further oral bioavailability by reducing drug-leakage in the gastrointestinal tract. Nanomedicine. 2018;14(4):1455–1464. doi:10.1016/j.nano.2017.08.009
   Web of Science ®Google Scholar
• Chen S, Zhang J, Wu L, Wu H, Dai M. Paeonol nanoemulsion for enhanced oral bioavailability: optimization and mechanism. Nanomedicine. 2018;13(3):269–282. doi:10.2217/nnm-2017-027729338580
   PubMed Web of Science ®Google Scholar
• Cilek A, Celebi N, Tirnaksiz F, Tay A. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Int J Pharm. 2005;298(1):176–185. doi:10.1016/j.ijpharm.2005.04.01615950411
   PubMedGoogle Scholar
• Elsayed A, Al Remawi M, Qinna N, Farouk A, Badwan A. Formulation and characterization of an oily-based system for oral delivery of insulin. Eur J Pharm Biopharm. 2009;73(2):269–279. doi:10.1016/j.ejpb.2009.06.00419508890
   PubMed Web of Science ®Google Scholar
• Rao SVR, Yajurvedi K, Shao J. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs III. In vivo oral absorption study. Int J Pharm. 2008;362(1–2):16–19. doi:10.1016/j.ijpharm.2008.05.01518650037
   PubMedGoogle Scholar
• Qin L, Niu Y, Wang Y, Chen X. Combination of phospholipid complex and submicron emulsion techniques for improving oral bioavailability and therapeutic efficacy of water-insoluble drug. Mol Pharmaceut. 2018;15(3):1238–1247. doi:10.1021/acs.molpharmaceut.7b01061
   PubMed Web of Science ®Google Scholar
• Zhao YQ, Wang LP, Ma C, Zhao K, Liu Y, Feng NP. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers. Int J Nanomedicine. 2013;8:4169–4181. doi:10.2147/IJN.S5055724204145
   PubMed Web of Science ®Google Scholar
• Cui F, Shi K, Zhang LQ, Tao AJ, Kawashima Y. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release. 2006;114(2):242–250. doi:10.1016/j.jconrel.2006.05.01316859800
   PubMed Web of Science ®Google Scholar
• Niu Z, Samaridou E, Jaumain E, et al. PEG-PGA enveloped octaarginine-peptide nanocomplexes: an oral peptide delivery strategy. J Control Release. 2018;276:125–139. doi:10.1016/j.jconrel.2018.03.00429518466
   PubMed Web of Science ®Google Scholar
• Metre S, Mukesh S, Samal SK, Chand M, Sangamwar AT. Enhanced biopharmaceutical performance of rivaroxaban through polymeric amorphous solid dispersion. Mol Pharmaceut. 2018;15(2):652–668. doi:10.1021/acs.molpharmaceut.7b01027
   PubMed Web of Science ®Google Scholar
• Wu L, Liu M, Shan W, et al. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs. J Control Release. 2017;262:273–283. doi:10.1016/j.jconrel.2017.07.04528774842
   PubMed Web of Science ®Google Scholar
• Zhou C, Xia X, Liu Y, Li L. The preparation of a complex of insulin-phospholipids and their interaction mechanism. J Pept Sci. 2012;18(9):541–548. doi:10.1002/psc.242322833363
   PubMedGoogle Scholar
• Wu J, Zheng Y, Liu M, Shan W, Zhang Z, Huang Y. Biomimetic viruslike and charge reversible nanoparticles to sequentially overcome mucus and epithelial barriers for oral insulin delivery. ACS Appl Mater Interfaces. 2018;10(12):9916–9928. doi:10.1021/acsami.7b1652429504398
   PubMed Web of Science ®Google Scholar
• Pangeni R, Choi JU, Panthi VK, Byun Y, Park JW. Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect. Int J Nanomedicine. 2018;13:3329–3351. doi:10.2147/IJN.S16795829922055
   PubMed Web of Science ®Google Scholar
• Cheng MB, Wang JC, Li YH, et al. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme. J Control Release. 2008;129(1):41–48. doi:10.1016/j.jconrel.2008.03.01818474405
   PubMedGoogle Scholar
• Halberg IB, Lyby K, Wassermann K, Heise T, Zijlstra E, Plum-Morschel L. Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial. Lancet Diabetes Endocrinol. 2019;7(3):179–188. doi:10.1016/S2213-8587(18)30372-330679095
   PubMed Web of Science ®Google Scholar